Injectability and mechanical properties of borneol-based solvent removal-induced in situ matrix for periodontal pocket delivery
Main Article Content
Abstract
Solvent removal-induced in situ matrices (ISMs) have garnered attention for periodontitis treatment because of their capability to localize antibiotic drug release within the periodontal pocket over an extended duration, effectively targeting and eliminating infecting microbes. In this study, various concentrations of borneol—10%–70%—were used as a matrix agent in ISMs, with a 40% w/w borneol-based ISM selected to load 1% vancomycin HCl. The injectability and mechanical properties of drug-free and vancomycin HCl-loaded borneol ISMs were evaluated with a texture analyzer. Both maximum injection force and energy increased proportionally with borneol concentrations and slightly further with vancomycin HCl. Nevertheless, the injection energy required for borneol-loaded ISMs at 10%–50% was low, from 12.22–25.00 mJ. Consequently, these formulations were considered appropriate and feasible as injectable drug delivery systems, providing ease of administration while promoting patient comfort and compliance. Additionally, a more compact borneol matrix was formed after complete solvent removal; it exhibited plastic deformation, enabling close adaptation to the periodontal pocket geometry.
Article Details

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
References
Stringer G. Chronic periodontitis, dantamoolaroga, indicates chronic systemic inflammation and reduces longevity. J Ayurveda Integr Med. 2024;15(6):101048.
H.R R, Dhamecha D, Jagwani S, Rao M, Jadhav K, Shaikh S, et al. Local drug delivery systems in the management of periodontitis: A scientific review. J Control Release. 2019;307:393–409.
Greenstein G. Local drug delivery in the treatment of periodontal diseases: Assessing the clinical significance of the results. J Periodontol. 2006;77(4):565–578.
Mahadlek J, Tuntarawongsa S, Senarat S, Phaechamud T. In situ solvent removal-based Eudragit® L/dimethyl sulfoxide forming gel for periodontal pocket drug delivery. Mater Today Proc. 2022;52:2394–2399.
Karp F, Turino LN, Helbling IM, Islan GA, Luna JA, Estenoz DA. In situ formed implants, based on PLGA and Eudragit Blends, for novel florfenicol controlled release formulations. J Pharm Sci. 2021;110(3):1270–1278.
Hu X, Yan Y, Liu W, Liu J, Fan T, Deng H, et al. Advances and perspectives on pharmacological activities and mechanisms of the monoterpene borneol. Phytomedicine. 2024;132:155848.
Mei Y, Li L, Fan L, Fan W, Liu L, Zhang F, et al. The history, stereochemistry, ethnopharmacology and quality assessment of borneol. J Ethnopharmacol. 2023;300:115697.
Tang M, Zhong W, Guo L, Zeng H, Pang Y. Role of borneol as enhancer in drug formulation: A review. Chin Herb Med 2024;17:473–483.
Zhang Q, Wu D, Wu J, Ou Y, Mu C, Han B, et al. Improved blood–brain barrier distribution: Effect of borneol on the brain pharmacokinetics of kaempferol in rats by in vivo microdialysis sampling. J Ethnopharmacol. 2015;162:270–277.
Lertsuphotvanit N, Santimaleeworagun W, Narakornwit W, Chuenbarn T, Mahadlek J, Chantadee T, et al. Borneol-based antisolvent-induced in situ forming matrix for crevicular pocket delivery of vancomycin hydrochloride. Int J Pharm. 2022;617:121603.
Citron DM, Tyrrell KL, Merriam CV, Goldstein EJ. In vitro activities of CB-183,315, vancomycin, and metronidazole against 556 strains of Clostridium difficile, 445 other intestinal anaerobes, and 56 Enterobacteriaceae species. Antimicrob Agents Chemother. 2012;56(3):1613–1615.
Argenziano M, Banche G, Luganini A, Finesso N, Allizond V, Gulino GR, et al. Vancomycin-loaded nanobubbles: A new platform for controlled antibiotic delivery against methicillin-resistant Staphylococcus aureus infections. Int J Pharm. 2017;523(1):176–188.
Do MP, Neut C, Delcourt E, Seixas Certo T, Siepmann J, Siepmann F. In situ forming implants for periodontitis treatment with improved adhesive properties. Eur J Pharm Biopharm. 2014;88(2):342–350.
Bode C, Kranz H, Siepmann F, Siepmann J. In-situ forming PLGA implants for intraocular dexamethasone delivery. Int J Pharm. 2018;548(1):337–348.
Phaechamud T, Mahadlek J, Chuenbarn T. In situ forming gel comprising bleached shellac loaded with antimicrobial drugs for periodontitis treatment. Mater Des. 2016;89:294–303.
Srichan T, Phaechamud T. Designing solvent exchange-induced in situ forming gel from aqueous insoluble polymers as matrix base for periodontitis treatment. AAPS Pharm Sci Tech. 2016;18(1):194–201.
Rungseevijitprapa W, Bodmeier R. Injectability of biodegradable in situ forming microparticle systems (ISM). Eur J Pharm Sci. 2009;36:524–553.
Agossa K, Lizambard M, Rongthong T, Delcourt-Debruyne E, Siepmann J, Siepmann F. Physical key properties of antibiotic-free, PLGA/HPMC-based in-situ forming implants for local periodontitis treatment. Int J Pharm. 2017;521(1-2):282–293.